The final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...

New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results ...

An innovative new treatment for tackling some of the toughest stomach cancers has shown promise in a phase 2 clinical trial, ...

Following these outcomes, Sun Pharma has decided to discontinue further clinical trials of SCD-044 and has no plans for its ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

The trial, which was funded by a National Institute for Health and Care Research (NIHR) Health Technology Assessment grant, ...

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...

At a panel at CTO West Coast, experts from biopharmaceutical companies outlined innovative strategies to shape the future of ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

For decades, the theory that has dominated Alzheimer’s research, and drug pipelines, is known as the amyloid hypothesis ...

Enrollment in a patient-delivered intervention allowed adults with overweight or obesity to better maintain weight loss than ...